BioLineRx Ltd. (NASDAQ:BLRX) Q1 2025 Earnings Call Transcript May 27, 2025
BioLineRx Ltd. beats earnings expectations. Reported EPS is $1.39, expectations were $-0.84.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to BioLineRx First Quarter 2025 Financial Results Conference Call. All participants are presently in a listen-only mode. Following managements formal presentation, instructions will be given for the question-and-answer session. I would now like to turn over the...
